Woodstock Sterile Solutions
Woodstock, IL
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Woodstock Sterile Solutions
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Woodstock, IL
- Modalities
- BFS plastic vials/ampoules, Sterile ophthalmic, Respiratory/inhalation, Oral liquid, Otic
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Woodstock Sterile Solutions
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBFS plastic vials/ampoules, Sterile ophthalmic, Respiratory/inhalation, Oral liquid, Otic
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press8 articles
Broad modality coverage (5 modalities)
Recent News 8 articles
SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions - Contract Pharma
Woodstock Sterile Solutions Completes Analytical Lab Expansion - Contract Pharma
Emergent BioSolutions appoints new executives to leadership team - The Business Journals
New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO - Fierce Pharma
Leading with Precision: Nick Buschur on Driving Growth and Innovation at Woodstock Sterile Solutions - Contract Pharma
After its breakout from Catalent, Woodstock Sterile Solutions emerges as a CDMO solo act - Fierce Pharma
Considering Blow-Fill-Seal for Biologic Drugs - BioPharm International
Parenteral and Sterile Fill-Finish Development and Manufacturing Trends - Contract Pharma
Frequently Asked Questions About Woodstock Sterile Solutions
What is Woodstock Sterile Solutions's CDMO Signal Score?
Woodstock Sterile Solutions has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Woodstock Sterile Solutions for a manufacturing program?
Use the free AI matchmaker to compare Woodstock Sterile Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.